ArticleJournal of clinical microbiology2000
Recovery of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Israel.
Article in Journal of clinical microbiology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 114 citations in OpenAlex.
- Rare case of spontaneous extraperitoneal bladder rupture in an elderly bedbound female: a case report.AME case reports · 2025Article
- Exploring the Biology, Virulence, and General Aspects ofInfection and drug resistance · 2024Review
- Phenotypic and genotypic detection of Candida albicans and Candida dubliniensis strains isolated from oral mucosa of AIDS pediatric patients.Revista do Instituto de Medicina Tropical de Sao Paulo · 2017Article
- In vitro adhesion of oral Candida dubliniensis isolates to acrylic denture surfaces following brief exposure to sub-cidal concentrations of polyenes, azoles and chlorhexidine.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2015Article
- The effect of psychoactive substances (drugs) on the presence and frequency of oral Candida species and Candida dubliniensis.Materia socio-medica · 2013Article
- Candida dubliniensis encrustation of an obstructing upper renal tract calculus.BMJ case reports · 2013Article
- Article
- First isolation of Candida dubliniensis from oral cavities of dermatological patients in Nanjing, China.Mycopathologia · 2011Article
- Candida dubliniensis: epidemiology and phenotypic methods for identification.Mycopathologia · 2010Review
- A Ser29Leu substitution in the cytosine deaminase Fca1p is responsible for clade-specific flucytosine resistance in Candida dubliniensis.Antimicrobial agents and chemotherapy · 2009Article
- Genetic relatedness of subgingival and buccal Candida dubliniensis isolates in immunocompetent subjects assessed by RAPD-PCR.Journal of oral microbiology · 2009Article
- Multilocus sequence typing reveals that the population structure of Candida dubliniensis is significantly less divergent than that of Candida albicans.Journal of clinical microbiology · 2008Article
- Novel 5-flucytosine-resistant clade of Candida dubliniensis from Saudi Arabia and Egypt identified by Cd25 fingerprinting.Journal of clinical microbiology · 2005Article
- The first clinical isolates of Candida dubliniensis in Slovakia.Mycopathologia · 2005Article
- Tobacco agar, a new medium for differentiating Candida dubliniensis from Candida albicans.Journal of clinical microbiology · 2004Article
- Differentiation of Candida dubliniensis from Candida albicans on Pal's agar.Journal of clinical microbiology · 2003Article
- Molecular mechanisms of itraconazole resistance in Candida dubliniensis.Antimicrobial agents and chemotherapy · 2003Article
- Candida dubliniensis at a university hospital in Saudi Arabia.Journal of clinical microbiology · 2003Article
- Casein agar: a useful medium for differentiating Candida dubliniensis from Candida albicans.Journal of clinical microbiology · 2003Article
- Susceptibility of Candida dubliniensis to salivary histatin 3.Antimicrobial agents and chemotherapy · 2003Article
Corrections and comments
- Commented on by
Authors and funding
6 authors at 4 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Candida dubliniensis is a recently discovered yeast species principally associated with carriage and disease in the oral cavities of human immunodeficiency virus (HIV)-infected individuals. To date the majority of isolates of this species have been identified in Europe and North America. In this study, five Candida isolates recovered from separate HIV-negative hospitalized patients in Jerusalem, Israel, were presumptively identified as C. dubliniensis on the basis of their dark green coloration when grown on CHROMagar Candida medium. Their identification was confirmed by a variety of techniques, including carbohydrate assimilation profiles, absence of growth at 45 degrees C, positive reaction with C. dubliniensis-specific antibodies as determined by indirect immunofluorescence analysis, and positive amplification with C. dubliniensis-specific PCR primers. All five strains were shown to be susceptible to a range of antifungal agents, including fluconazole. One of the five isolates was recovered from urine specimens, while the remaining four were recovered from upper respiratory tract and oral samples. While none of the patients was HIV positive, all were receiving broad-spectrum antibacterials at the time isolates of C. dubliniensis were obtained from clinical specimens. This study describes the first isolates of C. dubliniensis from the Middle East and confirms that this yeast can be associated with carriage and infection in the absence of HIV infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.